---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-061558"
form_type: "8-K"
ticker: "SKYE"
cik: "0001516551"
company_name: "Skye Bioscience, Inc."
filed_at: "2026-09-11T20:13:35+00:00"
generated_at: "2026-09-11T20:15:10.637018+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Skye CFO Sharp resigns, CEO Dhillon becomes principal financial officer; regains Nasdaq compliance

## Summary
- CFO John P. Sharp resigned Sept. 8, 2026; not due to disagreement with auditors or company.
- CEO Punit Dhillon appointed principal financial and accounting officer effective Sept. 8, 2026; compensation unchanged.
- Master Services Agreement with Lohman & Associates terminated effective Sept. 8, 2026.
- Nasdaq confirmed bid price >=$1.00 for 10 consecutive business days (Aug 24-Sep 4, 2026); compliance regained.

## SEC filing metadata
- accession: 0001628280-26-061558
- form_type: 8-K
- ticker: SKYE
- cik: 0001516551
- company_name: Skye Bioscience, Inc.
- filed_at: 2026-09-11T20:13:35+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.02, 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1516551/000162828026061558/0001628280-26-061558-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1516551/000162828026061558/skye-20260908.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-061558
- JSON: https://secwatch.observer/filing/0001628280-26-061558.json
- Plain text: https://secwatch.observer/filing/0001628280-26-061558.txt

## Key facts
- Executive change
  Punit Dhillon was appointed as Principal Financial and Accounting Officer at Skye Bioscience, Inc..
  - Action: appointed
  - Role: Principal Financial and Accounting Officer
  source text: In connection with Mr. Sharp’s departure, on September 9, 2026, the Board of Directors of the Company appointed Punit Dhillon, the Company’s President and Chief Executive Officer, as the Company’s principal financial and accounting officer, effective as of September 8, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1516551/000162828026061558/0001628280-26-061558-index.htm
- Executive change
  John P. Sharp resigned as Chief Financial Officer at Skye Bioscience, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On September 8, 2026, John P. Sharp resigned as Chief Financial Officer and principal financial and accounting officer of the Company, effective as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1516551/000162828026061558/0001628280-26-061558-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.